Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Tempest Therapeutics Inc increased its cash reserves by 25.56%, or 8.08m. Cash Flow from Financing totalled 35.60m or -- of revenues. In addition the company used 27.36m for operations while cash used for investing totalled 170.00k.
Cash flow per share | -1.60 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6921 |
---|---|
Tangible book value per share | 0.6921 |
More ▼
Balance sheet in USDView more
Current ratio | 2.17 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.6289 |
---|---|
Total debt/total capital | 0.3861 |
More ▼